Speaker illustration

Professor William Abraham

The Ohio State University, Columbus (United States of America)

Member of:

European Society of Cardiology
Heart Failure Association

Dr. Abraham earned his MD from Harvard Medical School and completed post-graduate training in Internal Medicine, Cardiovascular Medicine, and Advanced Heart Failure/Transplant Cardiology at the University of Colorado. At Ohio State University, Dr. Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years. His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, baroreflex activation therapy, and mitral valve repair. He has authored more than 1,000 original works and been named a Clarivate Analytics Highly Cited Researcher and one of The World’s Most Influential Scientific Minds. He received the 2017 Distinguished Scientist Award from the American College of Cardiology.

Diagnostic and prognostic value of biomarkers in acute heart failure

Event: Heart Failure 2022

Topic: Biomarkers

Session type: Symposium

Thumbnail

Big Brother is watching you: role of telemonitoring in the management of advanced heart failure.

Event: Heart Failure 2022

Topic: Remote Patient Monitoring and Telehealth

Session type: HowTo

Thumbnail

Rapid parade of devices: emerging treatment options in heart failure, Part 2

Event: Heart Failure 2021 Online Congress

Topic: Treatment

Session type: Special Session

Thumbnail

Expert opinion on heart failure management: devices

Event: Heart Failure 2021 Online Congress

Topic: Chronic Heart Failure

Session type: Special Session

Thumbnail

Treating common comorbidities (iron deficiency and sleep apnoea)

Event: Heart Failure 2021 Online Congress

Topic: Chronic Heart Failure

Session type: Symposium

Thumbnail

Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!

Event: ESC Congress 2018

Topic: Valvular Heart Disease

Session type: Satellite Symposium

Thumbnail

Functional mitral and tricuspid regurgitation: will novel transcatheter options redefine the landscape?

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Valvular Heart Disease

Session type: Satellite Symposium

Thumbnail

Treating Functional Mitral Regurgitation (FMR) in heart failure: time for evidence!

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Treatment

Session type: Satellite Symposium

Thumbnail

Valvular disease in heart failure: vicious twins

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Valvular heart disease

Session type: Symposium

Thumbnail

Tricuspid regurgitation in heart failure: how to treat it?

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Valvular heart disease

Session type: Satellite Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk